Daniel Char

Insider Reports History

Entity
Individual
Location
C/O Evelo Biosciences, Inc., 620 Memorial Drive, Suite 200, Cambridge, MA
Signature
/s/ Joseph J. Kenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Char:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP & CHIEF LEGAL OFFICER Common Stock 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. SVP & CHIEF LEGAL OFFICER Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. SVP & CHIEF LEGAL OFFICER Stock Option (Right to Buy) 0 $0 $4.56 Feb 12, 2024 Direct
Evelo Biosciences, Inc. General Counsel Stock Option (Right to Buy) 40K Jul 19, 2022 Direct

Insider Reports Filed by Daniel Char

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMGN ImmunoGen, Inc. Feb 12, 2024 3 $0 4 Feb 12, 2024 SVP & CHIEF LEGAL OFFICER
IMGN ImmunoGen, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 SVP & CHIEF LEGAL OFFICER
IMGN ImmunoGen, Inc. Nov 30, 2022 1 $2.08M 4 Nov 30, 2022 SVP & CHIEF LEGAL OFFICER
IMGN ImmunoGen, Inc. Nov 21, 2022 0 $0 3 Nov 30, 2022 SVP & CHIEF LEGAL OFFICER
EVLO Evelo Biosciences, Inc. Jul 19, 2022 1 $0 4 Oct 14, 2022 General Counsel
EVLO Evelo Biosciences, Inc. Jan 19, 2022 1 $0 4 Jan 21, 2022 General Counsel